PDF herunterladen
Semin Liver Dis 2009; 29(1): 121-133
DOI: 10.1055/s-0029-1192060
© Thieme Medical Publishers

Evolving Surgical Approaches in Liver Transplantation

Henrik Petrowsky1 , Ronald W. Busuttil1
  • 1The Dumount-UCLA Transplant Center, Ronald-Reagan UCLA Medical Center, Los Angeles, California
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. Februar 2009 (online)

    Lizenzen und Reprints

ABSTRACT

The growing discrepancy between the need and the availability of donor livers has resulted in evolving surgical approaches in liver transplantation during the last two decades to expand the donor pool. One approach is to transplant partial grafts, obtained either from a living donor or splitting a cadaveric donor liver. For both surgical methods, it is important to obtain a minimal viable graft volume to prevent small-for-size syndrome and graft failure. This minimal volume, expressed as graft-to-whole body ratio, must be between 0.8 and 1%. Living donor liver transplantation (LDLT) became the primary transplant option in many Asian countries and is increasingly performed as an adjunct transplant option in countries with low donation rates. Split liver transplantation (SLT) is a surgical method that creates two allografts from one deceased donor. The most widely used splitting technique is the division of the liver into a left lateral sectoral graft (segments 2 and 3) for a pediatric patient and a right trisegmental graft (segments 1 and 4 to 8) for an adult patient. Both LDLT and SLT are also important and established methods for the treatment of pediatric patients. Another evolving surgical approach is auxiliary liver transplantation, which describes the transplanting a whole or partial graft with preservation of the partial native liver. This bridging technique is applied in patients with fulminate liver failure and should allow the regeneration of the injured liver with the potential to discontinue immunosuppression. Other methods such as xenotransplantation, as well as hepatocyte and stem cell transplantation, are promising approaches that are still in experimental phases.

KEYWORDS

Liver transplantation - living donor liver transplantation - split liver transplantation - small-for-size syndrome - auxiliary liver transplantation - xenotransplantation - hepatocyte transplantation - stem cell transplantation - fulminate liver failure - end-stage liver failure

REFERENCES

  • 1 Available at: http://www.optn.org Accessed August 1, 2008
  • 2 Available at: http://www.eltr.org Accessed August 1, 2008
  • 3 Clavien P A, Petrowsky H, DeOliveira M L, Graf R. Strategies for safer liver surgery and partial liver transplantation.  N Engl J Med. 2007;  356 1545-1559
    CrossrefPubMedGoogle Scholar
  • 4 Cameron A M, Ghobrial R M, Yersiz H et al.. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants.  Ann Surg. 2006;  243 748-753 discussion 753-755
    CrossrefPubMedGoogle Scholar
  • 5 Strong R W, Lynch S V, Ong T H et al.. Successful liver transplantation from a living donor to her son.  N Engl J Med. 1990;  322(21) 1505-1507
    PubMedGoogle Scholar
  • 6 Kam I, Lynch S, Svanas G et al.. Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants.  Hepatology. 1987;  7 362-366
    CrossrefPubMedGoogle Scholar
  • 7 Dahm F, Georgiev P, Clavien P A. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications.  Am J Transplant. 2005;  5 2605-2610
    CrossrefPubMedGoogle Scholar
  • 8 Tian Y, Jochum W, Georgiev P et al.. Kupffer cell-dependent TNF-alpha signaling mediates injury in the arterialized small-for-size liver transplantation in the mouse.  Proc Natl Acad Sci U S A. 2006;  103 4598-4603
    CrossrefPubMedGoogle Scholar
  • 9 Bolognesi M, Sacerdoti D, Bombonato G et al.. Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size.  Hepatology. 2002;  35 601-608
    CrossrefPubMedGoogle Scholar
  • 10 Troisi R, Ricciardi S, Smeets P et al.. Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation.  Am J Transplant. 2005;  5 1397-1404
    CrossrefPubMedGoogle Scholar
  • 11 Trotter J F, Wachs M, Everson G T, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor.  N Engl J Med. 2002;  346 1074-1082
    CrossrefPubMedGoogle Scholar
  • 12 Tamura S, Sugawara Y, Kokudo N. Donor evaluation and hepatectomy for living-donor liver transplantation.  J Hepatobiliary Pancreat Surg. 2008;  15 79-91
    CrossrefPubMedGoogle Scholar
  • 13 Nakamuta M, Morizono S, Soejima Y et al.. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation.  Transplantation. 2005;  80 608-612
    CrossrefPubMedGoogle Scholar
  • 14 Testa G, Malagó M, Nadalin S et al.. Right-liver living donor transplantation for decompensated end-stage liver disease.  Liver Transpl. 2002;  8 340-346
    CrossrefPubMedGoogle Scholar
  • 15 New York State Department of Health .New York State Committee on Quality Improvement in Living Liver Donation. Available at: http://www.health.state.ny.us/nysdoh/liver_donation/recipients.htm Accessed August 1, 2008
    Google Scholar
  • 16 Tanaka K, Yamada T. Living donor liver transplantation in Japan and Kyoto University: what can we learn?.  J Hepatol. 2005;  42 25-28
    PubMedGoogle Scholar
  • 17 Middleton P F, Duffield M, Lynch S V et al.. Living donor liver transplantation–adult donor outcomes: a systematic review.  Liver Transpl. 2006;  12 24-30
    CrossrefPubMedGoogle Scholar
  • 18 Trotter J F, Adam R, Lo C M, Kenison J. Documented deaths of hepatic lobe donors for living donor liver transplantation.  Liver Transpl. 2006;  12 1485-1488
    CrossrefPubMedGoogle Scholar
  • 19 Morioka D, Egawa H, Kasahara M et al.. Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases.  Ann Surg. 2007;  245 315-325
    CrossrefPubMedGoogle Scholar
  • 20 Ghobrial R M, Freise C E, Trotter J F et al.. Donor morbidity after living donation for liver transplantation.  Gastroenterology. 2008;  135 468-476
    CrossrefPubMedGoogle Scholar
  • 21 Olthoff K M, Merion R M, Ghobrial R M et al.. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium.  Ann Surg. 2005;  242 314-323 discussion 323-325
    PubMedGoogle Scholar
  • 22 Tan H P, Patel-Tom K, Marcos A. Adult living donor liver transplantation: who is the ideal donor and recipient?.  J Hepatol. 2005;  43 13-17
    CrossrefPubMedGoogle Scholar
  • 23 Pichlmayr R, Ringe B, Gubernatis G, Hauss J, Bunzendahl H. Transplantation of a donor liver to 2 recipients (splitting transplantation) - a new method in the further development of segmental liver transplantation.  Langenbecks Arch Chir. 1988;  373 127-130
    PubMedGoogle Scholar
  • 24 Broelsch C E, Emond J C, Thistlethwaite J R et al.. Liver transplantation with reduced-size donor organs.  Transplantation. 1988;  45 519-524
    PubMedGoogle Scholar
  • 25 Yersiz H, Renz J F, Farmer D G et al.. One hundred in situ split-liver transplantations: a single-center experience.  Ann Surg. 2003;  238 496-505 discussion 506-507
    PubMedGoogle Scholar
  • 26 Bismuth H, Morino M, Castaing D et al.. Emergency orthotopic liver transplantation in two patients using one donor liver.  Br J Surg. 1989;  76 722-724
    CrossrefPubMedGoogle Scholar
  • 27 Adham M, Dumortier J, Abdelaal A et al.. Does middle hepatic vein omission in a right split graft affect the outcome of liver transplantation? A comparative study of right split livers with and without the middle hepatic vein.  Liver Transpl. 2007;  13 829-837
    CrossrefPubMedGoogle Scholar
  • 28 Renz J F, Emond J C, Yersiz H, Ascher N L, Busuttil R W. Split-liver transplantation in the United States: outcomes of a national survey.  Ann Surg. 2004;  239 172-181
    CrossrefPubMedGoogle Scholar
  • 29 Rogiers X, Sieders E. Split-liver transplantation: an underused resource in liver transplantation.  Transplantation. 2008;  86 493-499
    CrossrefPubMedGoogle Scholar
  • 30 Wilms C, Walter J, Kaptein M et al.. Long-term outcome of split liver transplantation using right extended grafts in adulthood: A matched pair analysis.  Ann Surg. 2006;  244 865-872 discussion 872-873
    CrossrefPubMedGoogle Scholar
  • 31 Cardillo M, De Fazio N, Pedotti P et al.. Split and whole liver transplantation outcomes: a comparative cohort study.  Liver Transpl. 2006;  12 402-410
    CrossrefPubMedGoogle Scholar
  • 32 Sebagh M, Yilmaz F, Karam V et al.. Cadaveric full-size liver transplantation and the graft alternatives in adults: a comparative study from a single centre.  J Hepatol. 2006;  44 118-125
    CrossrefPubMedGoogle Scholar
  • 33 Humar A, Beissel J, Crotteau S et al.. Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type.  Transplantation. 2008;  85 1420-1424
    CrossrefPubMedGoogle Scholar
  • 34 Bonney G K, Aldouri A, Attia M et al.. Outcomes in right liver lobe transplantation: a matched pair analysis.  Transpl Int. 2008;  21(11) 1045-1051
    PubMedGoogle Scholar
  • 35 Lee K W, Cameron A M, Maley W R, Segev D L, Montgomery R A. Factors affecting graft survival after adult/child split-liver transplantation: analysis of the UNOS/OPTN data base.  Am J Transplant. 2008;  8 1186-1196
    CrossrefPubMedGoogle Scholar
  • 36 Hong J C, Yersiz H, Farmer D et al.. Long-term outcome for whole and segmental liver grafts in adult and pediatric liver transplant recipients: a 10-year comparative analysis of 2377 cases. (paper in press)
    Google Scholar
  • 37 Sudan D L, Shaw Jr B W, Fox I J, Langnas A N. Long-term follow-up of auxiliary orthotopic liver transplantation for the treatment of fulminant hepatic failure.  Surgery. 1997;  122 771-777 discussion 777-778
    CrossrefPubMedGoogle Scholar
  • 38 Pereira S P, McCarthy M, Ellis A J et al.. Auxiliary partial orthotopic liver transplantation for acute liver failure.  J Hepatol. 1997;  26 1010-1017
    CrossrefPubMedGoogle Scholar
  • 39 Durand F, Belghiti J, Handra-Luca A et al.. Auxiliary liver transplantation for fulminant hepatitis B: results from a series of six patients with special emphasis on regeneration and recurrence of hepatitis B.  Liver Transpl. 2002;  8 701-707
    CrossrefPubMedGoogle Scholar
  • 40 Boudjema K, Bachellier P, Wolf P, Tempé J D, Jaeck D. Auxiliary liver transplantation and bioartificial bridging procedures in treatment of acute liver failure.  World J Surg. 2002;  26 264-274
    CrossrefPubMedGoogle Scholar
  • 41 van Hoek B, de Boer J, Boudjema K et al.. Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT Study Group. European Auxiliary Liver Transplant Registry.  J Hepatol. 1999;  30 699-705
    CrossrefPubMedGoogle Scholar
  • 42 Azoulay D, Samuel D, Ichai P et al.. Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure: a reappraisal from a single center by a case-control study.  Ann Surg. 2001;  234 723-731
    CrossrefPubMedGoogle Scholar
  • 43 Girlanda R, Vilca-Melendez H, Srinivasan P et al.. Immunosuppression withdrawal after auxiliary liver transplantation for acute liver failure.  Transplant Proc. 2005;  37 1720-1721
    CrossrefPubMedGoogle Scholar
  • 44 Lodge J P, Dasgupta D, Prasad K R et al.. Emergency subtotal hepatectomy: a new concept for acetaminophen-induced acute liver failure: temporary hepatic support by auxiliary orthotopic liver transplantation enables long-term success.  Ann Surg. 2008;  247 238-249
    CrossrefPubMedGoogle Scholar
  • 45 Gubernatis G, Pichlmayr R, Kemnitz J, Gratz K. Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report.  World J Surg. 1991;  15 660-665 discussion 665-666
    CrossrefPubMedGoogle Scholar
  • 46 Cooper D K, Gollackner B, Sachs D H. Will the pig solve the transplantation backlog?.  Annu Rev Med. 2002;  53 133-147
    CrossrefPubMedGoogle Scholar
  • 47 Yang Y G, Sykes M. Xenotransplantation: current status and a perspective on the future.  Nat Rev Immunol. 2007;  7 519-531
    CrossrefPubMedGoogle Scholar
  • 48 Lin S S, Kooyman D L, Daniels L J et al.. The role of natural anti-Gal alpha 1–3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants.  Transpl Immunol. 1997;  5 212-218
    CrossrefPubMedGoogle Scholar
  • 49 Lin S S, Hanaway M J, Gonzalez-Stawinski G V et al.. The role of anti-Galalpha1–3Gal antibodies in acute vascular rejection and accommodation of xenografts.  Transplantation. 2000;  70 1667-1674
    CrossrefPubMedGoogle Scholar
  • 50 Kuwaki K, Tseng Y L, Dor F J et al.. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience.  Nat Med. 2005;  11 29-31
    CrossrefPubMedGoogle Scholar
  • 51 Yamada K, Yazawa K, Shimizu A et al.. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue.  Nat Med. 2005;  11 32-34
    CrossrefPubMedGoogle Scholar
  • 52 Chen G, Qian H, Starzl T et al.. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys.  Nat Med. 2005;  11 1295-1298
    PubMedGoogle Scholar
  • 53 Cozzi E, Bhatti F, Schmoeckel M et al.. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts.  Transplantation. 2000;  70 15-21
    PubMedGoogle Scholar
  • 54 Zhong R, Luo Y, Yang H et al.. Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL.  Transplantation. 2003;  75 10-19
    CrossrefPubMedGoogle Scholar
  • 55 Lin S S, Weidner B C, Byrne G W et al.. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants.  J Clin Invest. 1998;  101 1745-1756
    CrossrefPubMedGoogle Scholar
  • 56 Ide K, Ohdan H, Kobayashi T et al.. Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells.  Xenotransplantation. 2005;  12 181-188
    CrossrefPubMedGoogle Scholar
  • 57 Fishman J A, Patience C. Xenotransplantation: infectious risk revisited.  Am J Transplant. 2004;  4 1383-1390
    CrossrefPubMedGoogle Scholar
  • 58 Takeuchi Y, Patience C, Magre S et al.. Host range and interference studies of three classes of pig endogenous retrovirus.  J Virol. 1998;  72 9986-9991
    PubMedGoogle Scholar
  • 59 Hara H, Gridelli B, Lin Y J, Marcos A, Cooper D K. Liver xenografts for the treatment of acute liver failure: clinical and experimental experience and remaining immunologic barriers.  Liver Transpl. 2008;  14 425-434
    CrossrefPubMedGoogle Scholar
  • 60 Starzl T E, Marchioro T L, Faris T D, McCardle R J, Iwaski Y. Avenues of future research in homotransplantation of the liver with particular reference to hepatic supportive procedures, antilymphocyte serum, and tissue typing.  Am J Surg. 1966;  112 391-400
    CrossrefPubMedGoogle Scholar
  • 61 Makowka L, Cramer D V, Hoffman A et al.. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure.  Transplantation. 1995;  59 1654-1659
    CrossrefPubMedGoogle Scholar
  • 62 Starzl T E, Fung J, Tzakis A et al.. Baboon-to-human liver transplantation.  Lancet. 1993;  341 65-71
    CrossrefPubMedGoogle Scholar
  • 63 Fisher R A, Strom S C. Human hepatocyte transplantation: worldwide results.  Transplantation. 2006;  82 441-449
    PubMedGoogle Scholar
  • 64 Alison M R, Choong C, Lim S. Application of liver stem cells for cell therapy.  Semin Cell Dev Biol. 2007;  18 819-826
    CrossrefPubMedGoogle Scholar
  • 65 Lagasse E, Connors H, Al-Dhalimy M et al.. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.  Nat Med. 2000;  6 1229-1234
    CrossrefPubMedGoogle Scholar
  • 66 Alison M R, Poulsom R, Jeffery R et al.. Hepatocytes from non-hepatic adult stem cells.  Nature. 2000;  406 257
    CrossrefPubMedGoogle Scholar
  • 67 Theise N D, Nimmakayalu M, Gardner R et al.. Liver from bone marrow in humans.  Hepatology. 2000;  32 11-16
    CrossrefPubMedGoogle Scholar
  • 68 Terai S, Ishikawa T, Omori K et al.. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.  Stem Cells. 2006;  24 2292-2298
    CrossrefPubMedGoogle Scholar
  • 69 Pai M, Zacharoulis D, Milicevic M N et al.. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis.  Am J Gastroenterol. 2008;  103 1952-1958
    CrossrefPubMedGoogle Scholar

Ronald W BusuttilM.D. Ph.D. 

The Dumount-UCLA Transplant Center, Ronald-Reagan UCLA Medical Center

757 Westwood Plaza, Suite 8236, Los Angeles, CA 90095-9574

eMail: rbusuttil@mednet.ucla.edu

      >